Learn more at LeadIQ.com

Insights

Recent IPO Success Artiva Biotherapeutics recently went public, raising $167 million in funding aimed at developing its AlloNK program for autoimmune diseases, presenting a potential sales opportunity to collaborate on research and development projects.

Strategic Partnerships The partnership with Lupus Therapeutics for a clinical trial testing AlloNK in lupus nephritis patients highlights Artiva's collaborative approach, indicating a potential sales opportunity for joint initiatives targeting lupus treatment solutions.

Award-Winning Innovation Artiva Biotherapeutics was recognized as the Immunology Innovation of the Year, showcasing its leadership in the field, which could be leveraged as a selling point to attract investors, partners, and customers.

Technology Stack Insights Artiva's tech stack includes various tools like Site Kit, NetSuite, and Smartsheet, suggesting a potential sales opportunity for tech integrations, software solutions, or IT services tailored to their specific needs.

Financial Health and Growth With revenues between $10-50 million and recent funding of $120 million, Artiva Biotherapeutics demonstrates financial stability and growth potential, offering a promising sales opportunity for financial services, investments, or strategic partnerships.

Similar companies to Artiva Biotherapeutics

Artiva Biotherapeutics Tech Stack

Artiva Biotherapeutics uses 8 technology products and services including Site Kit, MySQL, NetSuite, and more. Explore Artiva Biotherapeutics's tech stack below.

Site Kit
Analytics
MySQL
Database
NetSuite
E-commerce
Polyfill
Javascript Libraries
RSS
Miscellaneous
Smartsheet
Project Management
X-XSS-Protection
Security
WPMU DEV Smush
Web Platform Extensions

Media & News

Artiva Biotherapeutics's Email Address Formats

Artiva Biotherapeutics uses at least 1 format(s):

Artiva Biotherapeutics Email Formats	Example	Percentage
FLast@artivabio.com	JDoe@artivabio.com	50%
FLast@artivabio.com	JDoe@artivabio.com	50%

Frequently Asked Questions

Where is Artiva Biotherapeutics's headquarters located?

Artiva Biotherapeutics's main headquarters is located at 5505 Morehouse Drive, Suite 100 San Diego, California 92121 US. The company has employees across 3 continents, including North AmericaEuropeAfrica.

What is Artiva Biotherapeutics's stock symbol?

Artiva Biotherapeutics is a publicly traded company; the company's stock symbol is ARTV.

What is Artiva Biotherapeutics's official website and social media links?

Artiva Biotherapeutics's official website is artivabio.com and has social profiles on LinkedIn.

How much revenue does Artiva Biotherapeutics generate?

As of September 2024, Artiva Biotherapeutics's annual revenue reached $15M.

What is Artiva Biotherapeutics's SIC code NAICS code?

Artiva Biotherapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Artiva Biotherapeutics have currently?

As of September 2024, Artiva Biotherapeutics has approximately 82 employees across 3 continents, including North AmericaEuropeAfrica. Key team members include Chief Operating Officer: J. B.Chief Financial Officer: M. F.Chief Medical Officer: T. G.. Explore Artiva Biotherapeutics's employee directory with LeadIQ.

What industry does Artiva Biotherapeutics belong to?

Artiva Biotherapeutics operates in the Biotechnology Research industry.

What technology does Artiva Biotherapeutics use?

Artiva Biotherapeutics's tech stack includes Site KitMySQLNetSuitePolyfillRSSSmartsheetX-XSS-ProtectionWPMU DEV Smush.

What is Artiva Biotherapeutics's email format?

Artiva Biotherapeutics's email format typically follows the pattern of . Find more Artiva Biotherapeutics email formats with LeadIQ.

How much funding has Artiva Biotherapeutics raised to date?

As of September 2024, Artiva Biotherapeutics has raised $120M in funding. The last funding round occurred on Feb 26, 2021 for $120M.

When was Artiva Biotherapeutics founded?

Artiva Biotherapeutics was founded in 2019.

Artiva Biotherapeutics

Artiva Biotherapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

Artiva Biotherapeutics is an immunotherapy company with the ability to produce off-the-shelf, allogeneic NK cell therapies at a massive scale. Our mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers. Our lead program, AlloNK®, is an allogeneic, non-genetically modified NK cell therapy candidate designed to enhance the activity of monoclonal antibodies or NK cell engagers. AlloNK is currently in clinical trials in combination with rituximab for treatment of systemic lupus erythematosus (SLE) in patients with active lupus nephritis and for treatment of Non-Hodgkin Lymphoma, as well as in combination with Affimed’s innate cell engager AFM13 for the treatment of patients with relapsed/refractory CD30-positive lymphomas.

Company Overview

Headquarters: 5505 Morehouse Drive, Suite 100 San Diego, California 92121 US
Website: artivabio.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: ARTV
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2019
Employees: 51-200

Media & News

Funding & Financials

$120M
Artiva Biotherapeutics has raised a total of $120M of funding over 2 rounds. Their latest funding round was raised on Feb 26, 2021 in the amount of $120M.
$10M$50M
Artiva Biotherapeutics's revenue is in the range of $10M$50M

Funding & Financials

$120M
Artiva Biotherapeutics has raised a total of $120M of funding over 2 rounds. Their latest funding round was raised on Feb 26, 2021 in the amount of $120M.
$10M$50M
Artiva Biotherapeutics's revenue is in the range of $10M$50M

Company Leadership

J. B.
Chief Operating Officer
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. F.
Chief Financial Officer
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. G.
Chief Medical Officer
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
N. V.
Vice President Of Corporate Development & Allonk Program Lead
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. S.
Head Of Manufacturing Sciences
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

T. G.
Chief Medical Officer
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. B.
Director Of Information Technology (head Of It)
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
H. R.
Senior Vice President, Research And Early Development
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. S.
Head Of Manufacturing Sciences
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
E. H.
Senior Vice President, Regulatory Affairs
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Artiva Biotherapeutics and Millions of Other Companies
Sign up for full access to Artiva Biotherapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.